Medicare Enrolled

Dr. Sanjay Rao, M.D.

Ophthalmology · Oak Lawn, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
6201 W 95TH ST, Oak Lawn, IL 60453
7086369393
In practice since 2006 (20 years)
NPI: 1790738615 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rao

Dr. Sanjay Rao is an ophthalmology specialist in Oak Lawn, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rao performed 1,458 Medicare services across 1,030 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rao received a total of $65,951 from 38 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 1,458 Medicare services $65,951 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,458
Medicare services
Bottom 39% in IL for ophthalmology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,030
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
590 $88 $231
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
247 $27 $182
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
99 $92 $279
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
94 $406 $1,531
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
77 $29 $204
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
67 $44 $205
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
57 $257 $882
Insertion of drug delivery implant into tear duct
A small implant containing medication is placed into the tear duct of the eye to deliver drugs directly to the eye over time.
43 $14 $50
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
43 $23 $95
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
36 $30 $95
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
30 $84 $528
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
29 $51 $130
Complex cataract removal with lens implant
A surgical procedure to remove a cataract from the eye and insert an artificial lens to restore vision.
17 $613 $1,529
Dilation of eye fluid drainage
A procedure to widen the drainage pathways in the eye to help fluid flow out more easily.
16 $414 $1,200
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
13 $414 $1,725
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.4% high complexity
9.5% medium
84.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$65,951
Total received (2018-2024)
Avg $9,422/year across 7 years
Top 5% in IL for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$49,780 (75.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,770 (16.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,402 (8.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,329
2023
$772
2022
$12,482
2021
$8,013
2020
$5,176
2019
$25,868
2018
$12,310

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$354
Alcon Vision LLC
$216
Harrow Eye, LLC
$189
Sight Sciences, Inc.
$148
Bausch & Lomb Americas Inc.
$106
Glaukos Corporation
$61
Tarsus Pharmaceuticals, Inc.
$57
Genentech USA, Inc.
$35
NEW WORLD MEDICAL,INC.
$34
Johnson & Johnson Vision Care, Inc.
$31
ABBVIE INC.
$31
Rayner Intraocular Lenses Limited
$27
ANI Pharmaceuticals, Inc.
$26
RxSight Inc
$15
Top 3 companies account for 57.1% of 2024 payments
All-time payments by company (2018-2024) ›
Bausch & Lomb, a division of Bausch Health US, LLC
$27,216
EYEVANCE PHARMACEUTICALS LLC
$11,524
Shire North American Group Inc
$11,278
Eyevance Pharmaceuticals LLC
$3,931
EyePoint Pharmaceuticals US, Inc.
$2,968
Allergan, Inc.
$1,667
Kala Pharmaceuticals, Inc.
$1,341
Mallinckrodt Hospital Products Inc.
$916
Alcon Laboratories Inc
$817
Alcon Vision LLC
$734
AbbVie Inc.
$475
Sight Sciences, Inc.
$376
RxSight Inc
$371
Bausch & Lomb Americas Inc.
$286
ABBVIE INC.
$224
Novartis Pharmaceuticals Corporation
$197
Johnson & Johnson Surgical Vision, Inc.
$196
Harrow Eye, LLC
$189
Dompe US, Inc.
$189
SUN PHARMACEUTICAL INDUSTRIES INC.
$130
Vanda Pharmaceuticals Inc.
$99
ANI Pharmaceuticals, Inc.
$97
TissueTech, Inc.
$91
Johnson & Johnson Vision Care, Inc.
$72
Merz North America, Inc.
$70
Glaukos Corporation
$61
Tarsus Pharmaceuticals, Inc.
$57
Genentech USA, Inc.
$55
Sun Pharmaceutical Industries Inc.
$50
Thea Pharma Inc.
$44
Alimera Sciences, Inc.
$42
Optos, Inc.
$39
NEW WORLD MEDICAL,INC.
$34
Rayner Intraocular Lenses Limited
$27
Oyster Point Pharma, Inc.
$26
MERZ NORTH AMERICA, INC.
$24
Ocular Therapeutix, Inc.
$23
VYERA PHARMACEUTICALS, LLC
$17
Top 3 companies account for 75.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ARGOS · AcrySof · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY IOL · CEQUA · Cequa · Clareon · DEXYCU · DUREZOL · DURYSTA · Daraprim · ELAHERE · EYSUVIS · Flarex · HETLIOZ · HYDRUS Microstent · ILUVIEN · INVELTYS · Kahook Dual Blade · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX GEL · LOTEMAX SM · LUMIGAN · LenSx · MIEBO · NFC-700 · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · OZURDEX · PAZEO · PROLENSA · PURIFIED CORTROPHIN GEL · Precision 1 · Prokera · RAYNER CATARACT SET 1 · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSure Sealant · Rocklatan · TRAVATAN Z · TYRVAYA · TearScience Lipiview System · Tecnis 1-piece IOL · Tecnis IOL · TobraDex ST · Tobradex ST · VEVYE · VUITY · VYZULTA · Vabysmo · XDEMVY · XEOMIN · XIIDRA · YUTIQ · Zerviate · enVista MX60 IOL · iDose · iStent Trabecular Micro-Bypass System Model iS3
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for ophthalmology in IL.

Looking for an ophthalmology specialist in Oak Lawn?
Compare ophthalmologists in the Oak Lawn area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
586
Per 100K population
11.3
County median income
$81,797
Nearest hospital
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rao is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of IL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rao experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Rao performed 590 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rao receive payments from pharmaceutical companies?
Yes. Dr. Rao received a total of $65,951 from 38 companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rao's costs compare to other ophthalmologists in Oak Lawn?
Dr. Rao's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →